Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-012286
Filing Date
2020-05-14
Accepted
2020-05-14 16:27:13
Documents
48
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0320_citiuspharma.htm 10-Q 281005
2 ex31_1.htm EX-31.1 9087
3 ex31_2.htm EX-31.2 9058
4 ex32.htm EX-32.1 4867
  Complete submission text file 0001213900-20-012286.txt   2387421

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ctxr-20200331.xml EX-101.INS 335553
6 XBRL SCHEMA FILE ctxr-20200331.xsd EX-101.SCH 41983
7 XBRL CALCULATION FILE ctxr-20200331_cal.xml EX-101.CAL 35021
8 XBRL DEFINITION FILE ctxr-20200331_def.xml EX-101.DEF 123995
9 XBRL LABEL FILE ctxr-20200331_lab.xml EX-101.LAB 273724
10 XBRL PRESENTATION FILE ctxr-20200331_pre.xml EX-101.PRE 201651
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 20878193
SIC: 2834 Pharmaceutical Preparations